Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

Union trustees allege health plan documents didn’t allow for $4.3 million in drug spending that was cleared by pharmacy ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...

A doctor has revealed 'maintaining nutrition' while on weight-loss drugs like Mounjaro is 'crucial' for long-term health amid worrying survey results.

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...